New research suggests that patients who discontinue new weight-loss injections like semaglutide or tirzepatide tend to recover shed pounds far faster than those who halt traditional diet and exercise plans.
Published data in a major health publication shows that while obese people frequently drop substantial amounts of their total mass while using the jabs, the weight returns at an average rate of nearly a kilo each month upon discontinuation.
"People buying such treatments should be informed of the risk of fast rebound weight gain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb.
This pace of regain implies a reversion to original weight within about one and a half years.
Analyzing Treatments
The study, which looked at 37 of trials involving thousands of participants, compared the outcomes of GLP-1 agonists with other pills.
Scientists emphasize that individuals who lose weight through dieting usually have a slower weight regain—around 100 grams monthly—after stopping.
Understanding the Rapid Rebound
Experts believe the mechanism of the jabs accounts for the accelerated weight return.
These medications mimic a natural hormone called GLP-1, which helps regulate appetite.
"Long-term administration of the hormone concentrations several times higher than normal may cause the body to produce less of its own natural hormone, and could reduce responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this GLP-1 'fix' leads to hunger is no longer kept in check, making overeating much more probable."
A Lifelong Condition?
Health authorities advise the injections for individuals with weight-linked health risks, accompanied by recommended lifestyle changes.
Many experts argue that, given the significant potential of relapse, the therapy should be considered ongoing.
This opinion is supported by drug manufacturers, who note that the findings "emphasize the chronic character of excess weight," akin to managing diseases like high blood pressure.
User Testimonies
Individuals who have discontinued the jabs explain a intense resurgence of cravings.
"I experienced a trigger flipping and you become ravenous," recalled a patient.
This difficulty is exacerbated if individuals have not developed sustainable lifestyle or habit changes during treatment.
Growing Use
Figures indicate that a significant number of adults in the UK have used these injections in the last 12 months, with interest remaining high.
- Use is higher among females compared to males.
- The 40s and 50s age group shows the highest level of interest.
- A large proportion access the medications through private prescriptions rather than the NHS.
In conclusion, experts emphasize that while the jabs are potent agents for weight loss, they are not a permanent fix and maintained weight loss hinges on ongoing behavioural changes.
